Latest Technology Enhancement News

Resonance Health has reported record half-year revenue and strong progress in clinical trials, alongside promising new technology deployments set to enhance its global footprint.

RocketBoots Limited has secured a transformative $9.1 million annual contract with a major multinational retailer, alongside a $7 million capital raise to accelerate its international growth strategy.

Control Bionics has secured a two-year US distribution agreement with AAC leader PRC-Saltillo to broaden access to its NeuroNode technology, enhancing communication options for users with complex needs.

Vitasora Health Limited reported a significant 22% increase in daily clinical billing productivity for the December 2025 quarter, alongside a 17% rise in operating revenue. With new CMS reimbursement policies now in effect, the company anticipates a further 10–20% revenue uplift in 2026.

Adheris Health has received the final $6.1 million holdback payment from its Australian and New Zealand business sale, bringing total proceeds to $33.1 million and setting the stage for future earn-out payments.

Loyal Metals has confirmed a large, thick, near-surface copper-gold-silver mineralised zone at its Highway Reward project, alongside a new zinc-rich polymetallic discovery, signalling a potential shift to bulk-minable resources.

MetalsTech Limited is progressing its Pre-Feasibility Study for the Sturec Gold Mine in Slovakia, targeting completion in the first half of 2026, alongside key board appointments aimed at driving the project forward.

Temas Resources has completed a detailed airborne LiDAR survey at its Quebec projects, enhancing geological and engineering insights while progressing its proprietary Regenerative Chloride Leach technology aimed at slashing processing costs.

Saluda Medical has received CE certification for its EVA™ Sensing Technology, enabling commercialisation in Europe and recognition in Australia following prior FDA approval. This milestone sets the stage for a broader rollout of its personalised spinal cord stimulation therapy in early 2026.

HUB24 Limited showcased strong growth and strategic innovation at its 2025 Investor Strategy Day, highlighting market leadership and ambitious expansion plans across wealth management technology.

Temple & Webster Group delivered a robust FY25 with 21% revenue growth and expanded into New Zealand, reaffirming its ambitious growth and profitability targets for FY26.

Plenti Group Limited reported a robust half-year performance for 1H26, with a 24% increase in its loan portfolio and a 147% surge in Cash Profit Before Tax, underscoring its growing market presence and operational efficiency.